Investment thesis
Apollo Health Ventures invests in and co-founds early-stage biotechnology companies targeting aging and age-related disease. Working from Berlin with offices in Luxembourg and Boston, it backs teams across Europe and the United States in areas such as neurodegeneration, precision oncology and RNA-guided medicines. Alongside conventional venture funding, its Venture Lab builds new companies with scientific founders, with the aim of extending healthy lifespan.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Scripta Therapeutics Oxford, United Kingdom | Seed | Nov 2025 | €10.3M |